Non-ownership Filings
| Block Listing Six Monthly Return | Oct. 27, 2025 |
| Avacta presents preclinical data at AACR-NCI-EORTC | Oct. 27, 2025 |
| Notice of Investor Presentation | Oct. 23, 2025 |
| Equity fundraise of £16 million | Oct. 20, 2025 |
| Avacta Presents Phase 1a Data for Faridoxorubicin | Oct. 20, 2025 |
| Avacta to present data at EORTC-NCI-AACR | Oct. 13, 2025 |
| Interim Half Year Results 2025 | Sep. 30, 2025 |
Ownership Update Filings
| Director/PDMR Shareholdings and TVR | Sep. 02, 2024 |
| Director/PDMR Shareholding | Sep. 29, 2023 |
| Director/PDMR Shareholding | Nov. 08, 2022 |
| Director/PDMR Shareholding | Oct. 20, 2022 |
| Holding(s) in Company | Jun. 09, 2021 |
| Director/PDMR Shareholding | Oct. 22, 2020 |
| Holding(s) in Company | Aug. 11, 2020 |